Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultragenyx Pharmaceutical (RARE) Exchange Rate Effect (2017 - 2025)

Historic Exchange Rate Effect for Ultragenyx Pharmaceutical (RARE) over the last 9 years, with Q3 2025 value amounting to $294000.0.

  • Ultragenyx Pharmaceutical's Exchange Rate Effect fell 7694.12% to $294000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 million, marking a year-over-year increase of 10770.69%. This contributed to the annual value of -$2.5 million for FY2024, which is 64653.68% down from last year.
  • As of Q3 2025, Ultragenyx Pharmaceutical's Exchange Rate Effect stood at $294000.0, which was down 7694.12% from $2.9 million recorded in Q2 2025.
  • Ultragenyx Pharmaceutical's Exchange Rate Effect's 5-year high stood at $2.9 million during Q2 2025, with a 5-year trough of -$2.5 million in Q4 2024.
  • Its 5-year average for Exchange Rate Effect is $17052.6, with a median of -$136000.0 in 2023.
  • Per our database at Business Quant, Ultragenyx Pharmaceutical's Exchange Rate Effect crashed by 42180.09% in 2024 and then soared by 54969.14% in 2025.
  • Quarter analysis of 5 years shows Ultragenyx Pharmaceutical's Exchange Rate Effect stood at -$392000.0 in 2021, then soared by 444.9% to $1.4 million in 2022, then fell by 18.42% to $1.1 million in 2023, then crashed by 324.21% to -$2.5 million in 2024, then soared by 111.89% to $294000.0 in 2025.
  • Its last three reported values are $294000.0 in Q3 2025, $2.9 million for Q2 2025, and $1.4 million during Q1 2025.